The development of a sensitive, specific radioimmunoassay for morphine in biological fluids has permitted studies of the disposition of the drug in man (Berkowitz et al., 1975; Laitinen et al., 1975) . The value of such pharmacokinetic data is greater if they are related to measurement of biological effect. Although morphine has been used widely as an analgesic for many years, measurement of its clinical effect has been a major problem because methods used to assess pain and its relief are imprecise. This problem has been overcome to some extent by measuring side-effects, such as depression of lung ventilation. Despite many studies, there is no clear agreement on which ventilatory variables are the most precise measurements of theeffects of an opiate or on how narcotic drugs disturb ventilatory control (Eckenhoff and Oech, 1960; Campbell, Lister and McNicol, 1964; Jennett, 1968; Jennett, Barker and Forrest, 1968; Weil et al., 1975) . The present study was designed to assess the relationship between the disposition of morphine after i.m. injection and changes in ventilation (KE) and ventilatory response to carbon dioxide (Af^E/APcOg) in patients awaiting elective surgery. 0007-0912/78/0050-0759 S01.00
METHODS
Ventilation, mixed venous Pco 2 (Pv co^) and AKE/ A.Pco 2 were measured before and within 90 min after morphine 0.15 mgkg~1i.m. given into the right gluteal region of adult patients (American Society of Anesthesiologists physical status I or II) undergoing elective surgery under general anaesthesia. The plasma concentration of morphine was measured by radioimmunoassay in blood samples taken at 2, 4, 6, 8, 10, 15, 20, 30, 40, 50, 60, 90, 120, 150, 180 , and 240 min after injection.
Seventeen surgical patients were studied, six males and 11 females (mean age and SEM = 36.3 ± 3.9 yr, range = 21-68; mean vital capacity and SEM = 3.51 ±0.20 litre, range = 1.8-5.0). Informed consent was obtained from each patient. None gave a history of cardiovascular, respiratory or neurological disease and all had normal lung function as assessed by spirometry. All denied taking narcotic or other analgesic drugs in the 7 days preceding the study.
Ventilation was measured with a Parkinson-Cowan CD4 dry gas meter, which had a coefficient of variation of 2%. Carbon dioxide was measured with a Godart infra-red analyser, with a response time of 0.1 s, and a precision of ±0.1% over the range 0-10%. The gas sampling point was adjacent to the mouth-piece. The analyser was calibrated with three gas mixtures of carbon dioxide in 40% oxygen in nitrogen, analysed previously in a Lloyd-Haldane apparatus. A continuous record of end-tidal Pco 2 (PE'CO 2 ) an d ^E was obtained with an Astromed pen recorder. During rebreatbing, the gas sampled by the analyser was returned to the distal part of the bag to prevent recirculation of the sampled gas before complete re-mixing of the gas in the bag. The resistance of the rebreathing circuit was 1.0 cm H 2 O litre" 1 s at a flow rate of 4 litre s"
1 . All studies were performed in a quiet room adjacent to the operating room to minimize unnecessary stimulation. Each patient fasted for at least 4 h and emptied his or her bladder within 1 h of beginning an experiment. An i.v. infusion of saline 100-200 ml h" 1 was established at the beginning of each study and the infusion cannula was used for blood sampling for the measurement of the plasma concentration of morphine. The initial 2 ml drawn at each sampling was discarded to minimize the possibility of error resulting from dilution of the sample by saline.
Before each carbon dioxide response was measured, VE and PE' C02 were recorded for 2-3 min and Pv C02 was measured by Collier's rebreathing method (Collier, 1956 ). This measurement was used for each patient to adjust precisely the initial Pco 2 in the rebreathing bag for the ventilatory response to carbon dioxide measurement; the balance of gas in the bag was oxygen. The bag volume was adjusted to approximately 800 ml greater than the patient's VC, the minimum volume required to prevent the bag emptying during the large inspirations seen at the end of the period of rebreathing. Rebreathing was begun at the end-tidal position and the patient was immediately instructed to take three large breaths to mix the gas in the lungs and the bag and so attain the rapid equilibration between the bag and mixed venous blood. The appearance of a carbon dioxide plateau on the rebreathing record indicated that mixing of gas in the lungs and bag was complete and that an open loop was established between ventilation and Pco 2 (Rigg, Rebuck and Campbell, 1974) . In all experiments, such equilibration was observed within 20-40 s. Following the first three large breaths, a spontaneous pattern of ventilation was resumed, and rebreathing continued for 4 min. Preinjection measurements were obtained 30-60 min before the morphine was given. Patients who were not familiar with a mouth-piece and nose-clip or carbon dioxide rebreathing were allowed to become accustomed to these in a preliminary run.
Estimation of morphine in plasma
Plasma concentrations of morphine were estimated by radioimmunoassay. Morphine-specific antisera were raised in New Zealand white rabbits by immunization with morphine-6-succinyl-bovine serum albumin (Wainer et al., 1973) . To 50 fJitre of the patient's plasma sample (diluted 1: 5 with saline) 50(xlitre of l(n)-3H-morphine (28Cimmol-1 , 5000 ct min" 1 , New England Nuclear) and 100 [xlitre of antiserum (1 : 4000 dilution) were added. Samples were incubated overnight at 4 °C. Five hundred microlitres each of saline and charcoal solution in saline were added to each tube. After centrifugation, the supernatant fluid was transferred to counting vials and mixed with toluene-based scintillation fluid for counting for 4 min in a beta scintillation counter (Phillips' liquid scintillation analyser). A standard curve was obtained for each assay by adding known amounts of morphine to the tubes, in place of the unknown samples, employing identical experimental conditions. Each sample was analysed in duplicate.
Specificity of the method
The specificity of antisera and relative affinity for morphine, morphine metabolites and other opiate alkaloids have been described previously (Wainer et al., 1973) . In particular, morphine is bound by antibody five to six times more efficiently than is the major metabolite, morphine glucuronide (Hill et al., 1975) . The concentration of morphine in plasma is greater than the concentration of morphine glucuronide for up to 90 min after an i.m. injection (Berkowitz et al., 1975) . Thus, detection of glucuronide is unlikely to introduce a substantial error in the estimation of morphine concentration in the present study.
Data analysis
The slopes of the ventilatory responses to carbon dioxide were determined by least squares regression, according to the procedure of Read (1967) , in which ventilation is averaged over successive 30-s intervals and plotted against Pco 2 measured at the mid-point of each interval. Using this procedure, correlation coefficients for the linear regressions (mean and SEM) were: before injection, 0.94 + 0.015; after morphine, 0.89 + 0.030. To compare the position of response curves before and after morphine, two values of Pco 2 during rebreathing were chosen for each patient. These represented the highest (H) and the lowest (L) Pco 2 values, measured by the method described above, common to the two responses. Ventilations observed at these Pco 2 values were used to measure the position of the response curve. This procedure was adopted because different patients rebreathed over widely differing carbon dioxide pressures, as a consequence of widely differing Pv COa values between patients, both before and after morphine. Strict criteria for Pv C02 measurements were observed (Rigg, Rebuck and Campbell, 1974) and all measurements in the present study were within the wide range reported by Smedstad-Sealey, Rebuck and Campbell (1975) in their study of 202 normal subjects. The H and L ventilations ( VE S and KE L ) represented actual measurements during rebreathing. The use of these variables to estimate the position of the response curve eliminated errors as a result of extrapolation that would result if a single Pco 2 value was chosen to express the position of the response curve for all the patients.
The mean plasma concentration of morphine was computed for different sampling times after injection and the results were plotted semi-logarithmically. The elimination of morphine from plasma, following attainment of maximum plasma concentration (Cp max ), was assumed to be a single exponential function. Rate constants of elimination and half-lives were computed for each individual and mean values calculated.
The interrelationships of changes in ventilatory measurements after morphine and plasma morphine concentration were examined by plotting morphineinduced changes of Pv C02 , AKE/APCO 2 , KE L and FE H against maximum plasma morphine concentration and the mean of morphine concentrations measured immediately before and after the carbon dioxide response obtained after morphine.
The results were analysed using Student's t test and least squares regression analysis. 
RESULTS
The maximum plasma concentrations of morphine ranged from 30 to ^Ongml" 1 (mean and SEM: 62.4+6.2), occurring between 4 and 60min after injection (25.2 + 3.5). The mean disposition is shown in figure 1 . The rate constant for decay (k) of plasma concentration after Cp max was 5.6 + 0.5 ng min" 1 , corresponding to a half-life of 124 min (t t = 0.693/£).
Pv C02 (P< 0.001) and PE' C02 (P<0.01) breathing air, increased after morphine. Minute ventilation, FT and / decreased slightly, but these changes were not significant (table I; fig. 2 ). The response curve was displaced to the right (FE L and FE H ; P<0.001), and the mean slope decreased from 12.3 to 10.0 litre min" The maximum plasma morphine concentration and the mean of the concentration measured immediately before and after the carbon dioxide response after morphine did not correlate with the magnitude of drug-induced changes of ventilatory variables ( fig. 3 ).
DISCUSSION
The results of this study indicate that the absorption of morphine following i.m. injection is variable. Among 17 patients undergoing elective surgery, maximum plasma concentrations of morphine were attained between 4 and 60 min after injection and varied between 30 and 120 ng ml" 1 . These results are in close agreement with the data of Berkowitz and others (1975) , who studied the disposition of morphine following i.m. injection of similar doses in a comparable group. In their study morphine was also measured by radioimmunoassay.
The ventilatory effects of morphine differed. During rebreathing, displacement of the carbon dioxide response curve to the right was the major effect (table II, fig. 2 ). The findings are in good agreement with data from the literature which suggest consistent changes in position and equivocal or small changes in the slope of the response after morphine (Loeschke et al., 1953; Seed et al. 5 1958; Bellville, Cohen and Hamilton, 1964; Forrest and Bellville, 1964; Severinghaus and Larson, 1965 1966; Bellville and Fleischli, 1968; Jennett, Barker and Forrest, 1968; Weil et al., 1975) . During air breathing, a small but significant increase of Pv'co* an^ -P v co 2 was observed after morphine, reflecting progressive ventilatory depression and increased carbon dioxide body stores. Ventilation, Vr and / measured immediately before carbon dioxide response showed no significant change; this was probably a result of mild hyperventilation immediately before the second carbon dioxide response resulting from the patients' lack of familiarity No relationship was demonstrated between plasma morphine concentration and the magnitude of the ventilatory effects of the drug between subjects ( fig. 3 ) although both the plasma concentrations of morphine and the ventilatory effects varied widely among the patients studied. This finding is in contrast to predictions that the plasma concentration may be a useful and objective indicator of pharmacological activity (Berkowitz et al,, 1975) . It contrasts also with the correlation of depth of anaesthesia (as estimated by electroencephalography), with the arterial or alveolar anaesthetic concentration (Brazier, 1972) . To attempt to reconcile this apparent paradox, some of the assumptions upon which the relationship between plasma concentration and biological effect depend were examined.
The first assumption is that the drug binds reversibly with thetissuereceptor;thatis,thedrug-receptor interaction should obey the law of mass action: a valid assumption for morphine. Second, drug metabolites should not have pharmacological activity and should not be detected by the assay. The major metabolite of morphine, morphine glucuronide, has a minimal pharmacological effect. Morphine glucuronide is detected by the assay, but only one-fifth to one-sixth as efficiently as unconjugated morphine (Hill et al., 1975) . Moreover, within the first 90 min after injection, the concentration of morphine is greater than the concentration of morphine glucuronide (Berkowitz et al., 1975) . Thus, the latter is unlikely to lead to a substantial error in estimation of the active narcotic. This is supported by the close agreement of our results with those of Berkowitz and others (1975) , who demonstrated that their antiserum bound morphine glucuronide at one-eighth of the sensitivity of free morphine binding.
A third assumption is that drug tolerance does not interfere with the plasma concentration-biological effect relationship. Tolerance is a well-recognized property of morphine, but is generally considered to develop slowly. It is unlikely that acute tolerance developing within 2 h could cause such interference.
A fourth assumption is that the plasma concentration should bear a constant relationship to the active tissue concentration. While this may be true for many drugs in the elimination phase (Levine, 1973) , it may not be true for morphine during the first 2 h following an i.m. injection. This may reflect many factors affecting absorption and distribution from the site of injection and distribution to effector sites in the central nervous system. A further explanation of the lack of correlation observed between the plasma morphine concentration and the ventilatory effects may be the lack of specificity and sensitivity of the ventilatory variables used to quantitate the biological effect of the drug. This possibility is supported by recent physiological studies of mental influences on the ventilatory response to carbon dioxide (Rigg et al., 1977) and of pharmacological studies of effects on the ventilatory response to carbon dioxide in volunteers (Jennett, Barker and Forrest, 1968; Rigg and Goldsmith, 1976 
SUMARIO
Se estudio la relation entre la concentracion de morfina en la plasma y los cambios inducidos por morfina en la ventilation y respuesta ventilatoria al dioxido de carbono en 17 adultos saludables sometidos a cirugia electiva bajo anestesia general. A cada sujeto se le suministro sulfato de morfina 0,15 mg kg" 1 intramuscularmente; se midi6 la ventilation (VE), PCO 2 (PE'CO,) de final mareal, Pco 2 (Pvco,) venoso mezclado y la respuesta ventilatoria al dioxido de carbono ( AVE/ APCO 2 ) antes y al cabo de 90 min despues de la inyeccion. El Pco 2 venoso mezclado y el AT^E/ APCO 2 fueron medidos por metodos de reinspiracion normal; la concentracion de morfina en la plasma fue medida mediante una radioinmunoprueba. El contenido maximo de morfina en la plasma vario entre 30 y 120 ng ml" 1 , entre 4 y 60 min despues de la inyeccion. Se produjo un aumento significativo en el Pco 2 (P< 0,001) venoso mezclado, y PE'CO, (f<0,01) despues de la morfina, mientras que el VE disminuyo en forma insignificante. La morfina desplazo la curva de la respuesta del di6xido de carbono hacia la derecha (P<0,01) y el AFE/APCO 2 disminuyo de 12,3 a 10,0 litros min" 1 kPa" 1 (P<0,05). La magnitud de los cambios en VE y AKE/ APCO 2 no se relaciono a la concentracion maxima de morfina en la plasma ni a la concentracion media inmediatamente antes y despues de medirse la respuesta del dioxido de carbono. Las concentraciones de morfina en la plasma, bajo las condiciones del estudio actual, no constituyen un indicador objetivo de la actividad farmacologica entre un paciente y otro.
